Category: Biosimilars
Biosimilars market research reports by LP Information, Inc.
-
Global Rituximab Biosimilars Market Growth 2024-2030
Global Rituximab Biosimilars Market Growth 2024-2030 According to our LPI (LP Information) latest study, the global Rituximab Biosimilars market size was valued at US$ million in 2023. With growing demand in downstream market, the Rituximab Biosimilars is forecast to a readjusted size of US$ million ... Read More
-
Global Ranibizumab Drugs and Biosimilars Market Growth 2024-2030
Global Ranibizumab Drugs and Biosimilars Market Growth 2024-2030 Ranibizumab is a monoclonal antibody fragment that targets vascular endothelial growth factor(VEGF),used primarily in the treatment of eye diseases such as wet age-related macular degeneration(AMD)and diabetic eye disease.Biosimilars o ... Read More
-
Global G-CSF and G-CSF Biosimilars Market Growth 2024-2030
Global G-CSF and G-CSF Biosimilars Market Growth 2024-2030 According to our LPI (LP Information) latest study, the global G-CSF and G-CSF Biosimilars market size was valued at US$ million in 2023. With growing demand in downstream market, the G-CSF and G-CSF Biosimilars is forecast to a readjusted s ... Read More
-
Global Biosimilars Treatment Market Growth (Status and Outlook) 2024-2030
Global Biosimilars Treatment Market Growth (Status and Outlook) 2024-2030 According to our LPI (LP Information) latest study, the global Biosimilars Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilars Treatment is forecast to a readjuste ... Read More
-
Global Interchangeable Biosimilars Market Growth 2024-2030
Global Interchangeable Biosimilars Market Growth 2024-2030 An interchangeable biosimilar is a biopharmaceutical product that is similar to an approved reference biologic and has demonstrated equivalence in terms of quality, efficacy and safety. Interchangeable biosimilars may have minor differences ... Read More
-
Global Glycosylated Biosimilars Market Growth (Status and Outlook) 2024-2030
Global Glycosylated Biosimilars Market Growth (Status and Outlook) 2024-2030 According to our LPI (LP Information) latest study, the global Glycosylated Biosimilars market size was valued at US$ million in 2023. With growing demand in downstream market, the Glycosylated Biosimilars is forecast to a ... Read More
-
Global Peptides Biosimilars Market Growth (Status and Outlook) 2024-2030
Global Peptides Biosimilars Market Growth (Status and Outlook) 2024-2030 According to our LPI (LP Information) latest study, the global Peptides Biosimilars market size was valued at US$ million in 2023. With growing demand in downstream market, the Peptides Biosimilars is forecast to a readjusted s ... Read More
-
Global Recombinant Non-Glycosylated Proteins Biosimilars Market Growth (Status and Outlook) 2024-2030
Global Recombinant Non-Glycosylated Proteins Biosimilars Market Growth (Status and Outlook) 2024-2030 According to our LPI (LP Information) latest study, the global Recombinant Non-Glycosylated Proteins Biosimilars market size was valued at US$ million in 2023. With growing demand in downstream mark ... Read More
-
Global Biosimilars & Follow-on-Biologics Market Growth (Status and Outlook) 2024-2030
Global Biosimilars & Follow-on-Biologics Market Growth (Status and Outlook) 2024-2030 According to our LPI (LP Information) latest study, the global Biosimilars & Follow-on-Biologics market size was valued at US$ 22000 million in 2023. With growing demand in downstream market, the Biosimilars & Foll ... Read More
-
Global Retinal Biosimilars Market Growth (Status and Outlook) 2024-2030
Global Retinal Biosimilars Market Growth (Status and Outlook) 2024-2030 According to our LPI (LP Information) latest study, the global Retinal Biosimilars market size was valued at US$ million in 2023. With growing demand in downstream market, the Retinal Biosimilars is forecast to a readjusted size ... Read More
-
Global Erythropoietin (EPO) Drugs Market Growth 2024-2030
Global Erythropoietin (EPO) Drugs Market Growth 2024-2030 According to our LPI (LP Information) latest study, the global Erythropoietin (EPO) Drugs market size was valued at US$ 8958.6 million in 2023. With growing demand in downstream market, the Erythropoietin (EPO) Drugs is forecast to a readjust ... Read More
-
Global Biosimilars Market Growth 2024-2030
Global Biosimilars Market Growth 2024-2030 According to our LPI (LP Information) latest study, the global Biosimilars market size was valued at US$ 5602.9 million in 2023. With growing demand in downstream market, the Biosimilars is forecast to a readjusted size of US$ 18570 million by 2030 with a C ... Read More
-
Global Lucentis (Ranibizumab) and Biosimilar Market Growth 2023-2029
Global Lucentis (Ranibizumab) and Biosimilar Market Growth 2023-2029 The global Lucentis (Ranibizumab) and Biosimilar market size is projected to grow from US$ 1099.6 million in 2022 to US$ 910.1 million in 2029; it is expected to grow at a CAGR of -2.7% from 2023 to 2029. United States market for L ... Read More
-
Global Humira Biosimilar Market Growth 2023-2029
Global Humira Biosimilar Market Growth 2023-2029 The global Humira Biosimilar market size is projected to grow from US$ 411.8 million in 2022 to US$ 966.9 million in 2029; it is expected to grow at a CAGR of 13.0% from 2023 to 2029. The introduction of Humira biosimilars is expected to increase comp ... Read More
-
Global Herceptin (Trastuzumab) and Biosimilar Market Growth 2023-2029
Global Herceptin (Trastuzumab) and Biosimilar Market Growth 2023-2029 The global Herceptin (Trastuzumab) and Biosimilar market size is projected to grow from US$ 4413.9 million in 2022 to US$ 6202.2 million in 2029; it is expected to grow at a CAGR of 5.0% from 2023 to 2029. United States market for ... Read More
-
Global Bevacizumab Monoclonal Antibody Biosimilar Market Growth 2023-2029
Global Bevacizumab Monoclonal Antibody Biosimilar Market Growth 2023-2029 The global Bevacizumab Monoclonal Antibody Biosimilar market size is projected to grow from US$ 1311.8 million in 2022 to US$ 419.1 million in 2029; it is expected to grow at a CAGR of -15.0% from 2023 to 2029. United States m ... Read More
-
Global Epogen and Biosimilar Market Growth 2023-2029
Global Epogen and Biosimilar Market Growth 2023-2029 The global Epogen and Biosimilar market size is projected to grow from US$ 699.4 million in 2022 to US$ 554.3 million in 2029; it is expected to grow at a CAGR of -3.3% from 2023 to 2029. United States market for Epogen and Biosimilar is estimated ... Read More
-
Global Neulasta (Pegfilgrastim) and Biosimilar Market Growth 2023-2029
Global Neulasta (Pegfilgrastim) and Biosimilar Market Growth 2023-2029 The global Neulasta (Pegfilgrastim) and Biosimilar market size is projected to grow from US$ 2378.1 million in 2022 to US$ 3755 million in 2029; it is expected to grow at a CAGR of 6.7% from 2023 to 2029. United States market for ... Read More
-
Global Adalimumab (Humira) and Biosimilar Market Growth 2023-2029
Global Adalimumab (Humira) and Biosimilar Market Growth 2023-2029 The global Adalimumab (Humira) and Biosimilar market size is projected to grow from US$ 21930 million in 2022 to US$ 14950 million in 2029; it is expected to grow at a CAGR of -5.3% from 2023 to 2029. The expiration of patents for ada ... Read More
-
Global Thyrogen and Biosimilar Market Growth 2023-2029
Global Thyrogen and Biosimilar Market Growth 2023-2029 The global Thyrogen and Biosimilar market size is projected to grow from US$ 251.4 million in 2022 to US$ 721.6 million in 2029; it is expected to grow at a CAGR of 16.3% from 2023 to 2029. United States market for Thyrogen and Biosimilar is est ... Read More
-
Global Avastin Biosimilar Market Growth 2023-2029
Global Avastin Biosimilar Market Growth 2023-2029 The global Avastin Biosimilar market size is projected to grow from US$ 1311.8 million in 2022 to US$ 419.1 million in 2029; it is expected to grow at a CAGR of -15.0% from 2023 to 2029. United States market for Avastin Biosimilar is estimated to inc ... Read More
-
Global Enbrel (Etanercept) and Biosimilar Market Growth 2023-2029
Global Enbrel (Etanercept) and Biosimilar Market Growth 2023-2029 The global Enbrel (Etanercept) and Biosimilar market size is projected to grow from US$ 6211.9 million in 2022 to US$ 7862.4 million in 2029; it is expected to grow at a CAGR of 3.4% from 2023 to 2029. United States market for Enbrel ... Read More
-
Global Remicade (Infliximab) and Biosimilar Market Growth 2023-2029
Global Remicade (Infliximab) and Biosimilar Market Growth 2023-2029 The global Remicade (Infliximab) and Biosimilar market size is projected to grow from US$ 2494.5 million in 2022 to US$ 3703.9 million in 2029; it is expected to grow at a CAGR of 5.8% from 2023 to 2029. United States market for Rem ... Read More
-
Global Rituxan (Rituximab) and Biosimilar Market Growth 2023-2029
Global Rituxan (Rituximab) and Biosimilar Market Growth 2023-2029 The global Rituxan (Rituximab) and Biosimilar market size is projected to grow from US$ 4035.3 million in 2022 to US$ 5179.6 million in 2029; it is expected to grow at a CAGR of 3.6% from 2023 to 2029. United States market for Rituxan ... Read More
-
Global Enbrel (Etanercept) Biosimilar Market Growth 2023-2029
Global Enbrel (Etanercept) Biosimilar Market Growth 2023-2029 The global Enbrel (Etanercept) Biosimilar market size is projected to grow from US$ 1219.9 million in 2022 to US$ 1688.2 million in 2029; it is expected to grow at a CAGR of 4.8% from 2023 to 2029. United States market for Enbrel (Etanerc ... Read More
Research Assistance
